VivoSeq
Other

Mobility

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Mobility is an early-stage landscape with 0 programs across 1 company. The most active players are Astellas.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Astellas logo

Astellas

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

11

clinical trials

Completed5 · 45%
Unknown status4 · 36%
Terminated1 · 9%
Not yet recruiting1 · 9%

Clinical Trials

Trial Activity

11 trials

Kava Aging and Mobility Study
Not yet recruiting·UUniversity of Florida·Phase 1·NCT07219186·40 enrolled
Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry
Completed·MMclean Hospital·N/A·NCT05384470·32 enrolled
Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm
Completed·UUniversity of Michigan·Phase 1/2·NCT06219915·13 enrolled
Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm
Completed·UUniversity of Michigan·Phase 1/2·NCT06587217·5 enrolled
Neurobiological Drivers of Mobility Resilience: The Dopaminergic System
Completed·UUniversity of Michigan·Phase 1/2·NCT04325503·14 enrolled
Locomotor Adaptability for Community Mobility of Older Adults: The Role of Gait Automaticity
Completed·UUniversity of Pittsburgh·Preclinical·NCT04934956·44 enrolled
A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility
Terminated·Astellas logoAstellas·Phase 1·NCT03065959·42 enrolled
Impact of Urethral Mobility on the Success of Sling Operations
Unknown status·KKanuni Sultan Suleyman Training and Research Hospital·N/A·NCT02301013·140 enrolled
Effects of Butyrate Enemas on Postoperative Intestinal Mobility Disorders in Hirschsprung's Disease
Unknown status·AAssistance Publique Hopitaux De Marseille·Phase 3·NCT03660176·58 enrolled
Evaluation of High-Performance, Customized, Rapidly-Manufacturable Prosthetic Feet That Provide Improved Mobility
Unknown status·MMassachusetts Institute of Technology·N/A·NCT05265403·40 enrolled
Valuation of the Evolution of Passive Mobility in the Spastic Upper Limb After Injection of Abobotulinumtoxin(Dysport®)
Unknown status·FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·N/A·NCT05151874·12 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)